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ABSTRACT
HEART RATE VARIABILITY (HRV), CORTISOL, AND TRAIT ANXIETY IN MIDLIFE ADULTS

Meghan M. Bennett, M.S.
Marquette University, 2022

Heart rate variability (HRV) and cortisol are well-established biomarkers of the
human stress response system. As such, their respective relationships with trait anxiety
have been studied. As high HRV indicates healthy emotion regulation while low HRV
signifies poor emotion regulation, a negative relationship between HRV and anxiety is
found in the literature. Conversely, cortisol both prepares the body for stress and helps it
to recover and current studies yield mixed results on its relationship with anxiety. While
the link between vagal activity, which mediates HRV, and the HPA-axis, which outputs
cortisol, is generally assumed, few studies have examined these biomarkers in the same
study design, and specifically how this relationship, if present, manifests over time or in
relation to anxiety. Importantly, studying these biomarkers together provides a clearer
depiction of the stress response and may better inform treatments aimed at improving
biological outcomes in clinical samples, such as highly anxious individuals. Using
archival data from 438 mid-life adults, the impetus of the present study was to examine
the relationship between cortisol and HRV over time (pre-, during-, post- cognitive and
physical stressors) using standard, literature-defined metrics to quantify
increased/decreased cortisol and HRV in response to stress. Additionally, we used latent
growth mixture modeling (LGMM) to examine trajectories of cortisol and HRV over
time in response to stress. Finally, we tested the relationship between all measures of
cortisol and HRV to anxiety. Results revealed that in response to a cognitive stressor,
higher HRV reactivity was associated with higher cortisol reactivity. LGMM analyses
identified differential cortisol and HRV trajectories. Despite this and contrary to
hypothesis, we did not find support for a relationship between anxiety and HRV and
cortisol metrics, including differential trajectories of change, in the full sample. In
exploratory analyses, we did find that individuals with greater anxiety exhibited less
cortisol reactivity to the cognitive stressor when we restricted our analysis to a
“clinically-detectable” anxious sub-group. Results hold clinical relevance in that targeting
moment-to-moment adaption to stress via HRV may help promote more adaptive cortisol
responding via changing cortisol output. However, more research is needed to better
understand this relationship.
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Introduction
According to Darwin’s Origin of Species, it is not the most intellectual of the
species that survives; it is not the strongest that survives; but the species that
survives is the one that is best able to adapt and adjust to the changing
environment in which it finds itself. (Megginson, 1963, p. 4)
Fear is the response to an imminent or real threat (American Psychiatric
Association, 2013). For example, fear of a snake that has just moved on the path ahead of
you as you round a corner in your walk activates the hypothalamic-pituitary-adrenal
(HPA)-Axis and initiates a cascade of stress hormone release, a biological responses that
in part activates heart rate and muscle activity. Activation of this system initiates action
to help you avoid harm and is therefore considered adaptive (Rotenberg & McGrath,
2016). In contrast, anxiety is defined as the anticipation of future threat; that is, a
response to a real or imagined stimuli that one perceives as threatening, but which may or
may not put the organism in danger and for which the outcome is unknown. Clinically,
anxiety is the most common psychiatric disorder, surpassing depression, with an
estimated 12-month prevalence for anxiety disorder diagnoses in the United States at
18.1% (Chalmers et al., 2014; Kessler et al., 2005). Anxiety is also costly to treat, in part
because it is associated with a host of long-term deleterious psychological (e.g., the
development of diagnosable anxiety disorders) and physical (e.g., cardiovascular disease)
outcomes (Sylvers et al., 2011). An approximate $42.3 billion is spent annually on
treating this disorder across associated health care costs or estimated loss of work
revenue (Greenberg et al., 1999). Despite the prevalence, cost-burden, and clinical
certification of anxiety, the associated biological mechanisms of this disorder are still not
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fully understood. Critically, a clearer understanding of anxiety’s biological underpinnings
may be important to inform treatment approaches that target the underlying causes of
anxiety and mitigate its deleterious effects.
Because of the link between anxiety and biological response to threat, anxiety can
manifest in a variety of psychological, biological, and behavioral presentations, and be
measured in such responses. First, psychological cardinal symptoms of anxiety include
worry, hypervigilance, avoidance, and apprehension (Sylvers et al., 2011), while selfreport measures are a primary tool in assessing these symptoms (Sylvers et al., 2011).
Spielberger et al. (1983) defines trait anxiety as a relatively stable tendency of the
individual to manifest anxiety states, differing from state anxiety, which is described as
an unpleasant emotional state rooted in fear. Differences in state vs. trait anxiety are
measured using the State-Trait Anxiety Inventory (STAI), considered the gold-standard
self-report scale (Kayikcioglu et al., 2017). Using such metrics, trait anxiety is defined as
individual differences in how people tend to perceive stressful situations as threatening
and to respond to such situations with heightened and often prolonged intensity
(Spielberger et al., 1983). Importantly, ‘intensity’ is defined here as hormonal and
physiological response to perceived threat (Spielberger & Reheiser, 2009). Thus,
variation in two neurobiological systems associated with stress hormones and physiology,
the HPA-Axis and the autonomic nervous system (ANS), respectively, may be
particularly indicative of trait anxiety.
Biological Mechanisms of the Stress Response System
The HPA-Axis is the body’s hormonal response system and regulator of the stress
response (Rotenberg & McGrath, 2016). When a person encounters perceived threat, the
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hypothalamus releases a corticotrophin-releasing hormone, which in turn triggers the
pituitary gland to release adrenocorticotropic hormones (ACTH) into the blood stream.
The ACTH travels down to the adrenal glands prompting the release of cortisol, a steroid
hormone considered the main output of HPA-axis activation (Bozovic et al., 2013). Thus,
cortisol output serves as a reliable metric of biological response to stress (Bozovic et al.,
2013). Importantly, when cortisol levels in the blood become high, it induces a negative
feedback mechanism for termination of the stress response (Bozovic et al., 2013). Thus,
while a metric of activation of stress response, high cortisol after stress is considered
adaptive in that it serves an important role in shutting down further secretion of stress
hormones.
Cortisol also follows a known time course in healthy individuals. Upon exposure
to a stressor, the ACTH responds within in the first 5 minutes, while cortisol secretion
lags by 5-20 minutes (Bozovic et al., 2013). Thus, peak blood levels for measuring
cortisol are established within approximately 10-30 minutes following stress exposure.
Additionally, healthy individuals display a robust diurnal rhythm of cortisol response
irrespective of experienced stress, with cortisol levels peaking approximately 30 minutes
after waking, then declining throughout the day to reach their lowest in the evening
(Miller et al., 2007). As the transfer of cortisol from blood to saliva takes place between
2-3 minutes, cortisol can be measured in saliva, and due to its noninvasive nature and
ease at collecting samples across multiple time points, salivary measures of cortisol have
become a commonly used marker of cortisol output. After stress, rises in cortisol
measured in saliva are well-detected and occur approximately 20 minutes after exposure
to the stressor, before returning to baseline (e.g., pre-stress) levels (Kirschbaum &
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Hellhammer, 2000). Nevertheless, there is great variability in cortisol output. As one
example, average salivary cortisol levels among healthy subjects range from 0.20 – 1.41
μg/dl (5.52 – 28.92 nmol/l ) in the morning and between 0.04 – 0.41 μg/dl (1.10 – 11.32
nmol/l ) in the afternoon (Bozovic et al., 2013).
One of the main targets of cortisol activation is the autonomic nervous system
(ANS), which unconsciously regulates bodily functions. Divided into sympathetic and
parasympathetic branches, these systems work in a largely opposite fashion, activating or
inhibiting internal organs in response to perceived stress. One main target of the ANS is
the heart, as the ANS regulates heart rate through both sympathetic fibers and
parasympathetic innervations mediated by the vagus nerve (Sloan et al., 2017).
Sympathetic activation of the heart speeds up heart rate, while parasympathetic activation
decreases is (Thayer & Sternberg, 2006). One commonly-used marker of non-linear
adaptation of the heart to threat is called heart rate variability (HRV) and HRV has been
utilized as an individual-differences marker in the body’s adaptability to stress. More
concretely, HRV measures the heart’s flexible responding, which changes in response to
stress as well as over the day. That is, both cortisol and HRV follow time course patterns
in response to stress, while changes in HRV are also known to vary among individuals
(Friedman, 2007). For instance, high HRV, qualified by a relatively large inter-beat
variability (Berntson et al., 1997; Friedman, 2007; Rajcani et al., 2018) is associated with
intact emotion regulation, a main mechanism for the control of perceived stress or threat.
Conversely, low HRV is thought to reflect emotion dysregulation (Pulopulos et al.,
2018). Critically, although cortisol influences heart rate, individual differences in
underlying HRV prior to, during, and after stress has been heralded as an important driver
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at anxiety reduction (Pulopulos et al., 2018). That is, while cortisol influences HRV,
HRV also appears to serve as its own negative feedback targeting the stress response
itself. As a metric of HRV and specifically tied to activation of the parasympathetic
modulation of the heart, the root mean square successive difference (RMSSD) is a widely
used measure as it is considered to be mostly free of respiratory influences that are not of
cardinal interest when studying activation of the heart as it relates to stress (Hill &
Siebenbrock, 2009). To our knowledge, there are not well-established normative values
of what HRV, or RMSSD, variability should be in healthy individuals, which may be, in
part, due to extreme individual differences of HRV. Considering fear’s association with
activation of the HPA-axis, and in turn the ANS and associated HRV, trait anxiety may
be an important individual difference factor that contributes to this inconsistency (Thayer
et al., 1996). Indeed, current theory dictates that the etiology of anxiety may be rooted in
abnormal biological response to stress (Sapolsky, 1994).

Cortisol and Anxiety

Despite a strong theoretical assertion that stress responding is atypical in
individuals with anxiety, prior literature has found disparate evidence for whether cortisol
output after stress is indeed atypical, and whether it is increased or decreased in this
population. First, a growing number of studies demonstrate blunted cortisol response
(e.g., less rise after stress compared to healthy individuals) immediately following and
recovering from stress among anxious individuals (de Rooij et al., 2010; Fiksdal et al.,
2019; Jezova et al., 2004). More specifically, compared to peers with low trait anxiety,
adults with comparatively higher trait anxiety exhibit lower cortisol output 15, 30, and 90
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minutes after stress (Jezova et al., 2004). Similarly, in a large sample of middle-aged
adults salivary cortisol was measured at baseline, peak response to stressor, and recovery
within 30 minutes of stress exposure. Findings revealed that adults with higher trait
anxiety experienced blunted cortisol in peak response to the stressor compared to their
low-anxious counterparts, but cortisol at baseline and recovery did not significantly differ
between anxious and non-anxious individuals (de Rooij et al., 2010). Other work has
found that the recovery of cortisol to pre-stress levels is altered in those with high anxiety
and adds further evidence to a “blunted cortisol” theory of anxiety. For instance, Fiksdal
and colleagues (2019) found that greater anxiety was related to flattened cortisol slope
back to baseline after stress, meaning it took these individuals longer to return to a
baseline cortisol level. Takahashi et al. (2005) examined participants’ baseline, stress
reactivity, and post-stress cortisol levels and found respondents’ trait anxiety was
significantly positively correlated with both pre-stress cortisol levels, and that pre-stress
cortisol levels were inversely associated with stress-induced cortisol responding. That is,
lower pre-stress cortisol was related to greater stress-induced cortisol. In particular, these
findings suggest a functional relationship between cortisol measured at different
timepoints. One possibility is that trait anxiety is associated with time course of cortisol
response, not just overall cortisol output. Notably, prior studies have used varied stressors
ranging from a public speech task, Stroop test, and cognitive tasks and either studied
these effects in healthy individuals without a diagnosis of anxiety (but with trait anxiety
symptoms; e.g., Fiksdal et al., 2019) or in clinically-diagnosed patients with anxiety (e.g.,
de Rooij et al., 2010; however, only 2% clinically diagnosed). Thus, it appears that
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neither the type of stressor probe used nor the diagnostic status of participants seems to
alter the finding that greater anxiety symptoms is tied to lower cortisol output.
In contrast to the above, other studies suggest increased cortisol in this population
immediately through 60 minutes post-stress (Furlan et al., 2001; Yoon & Joormann,
2012). This is particularly true among individuals with socially related anxieties. For
example, Yoon & Joormann (2012) found that those with social anxiety experienced an
increased, and significantly different, cortisol response to the stressor compared to
healthy controls. Likewise, Furlan and colleagues (2001) found that individuals with
social phobias responded with higher cortisol levels compared to healthy controls in
response to a social stress task, but not to physical exercise. Thus, at least for some
individuals for which their anxiety manifests in social contexts, heightened cortisol may
depend on the type of stressor.
Still yet, other work has failed to find atypical cortisol responses tied to anxiety
(Henckens et al., 2016; Souza et al., 2015; Young et al., 2004). Elnazer & Baldwin
(2014) conducted a structured review of the literature and found no unifying HPA-Axis
response across anxiety disorders (e.g., generalized anxiety disorder, panic disorder,
specific phobias, and social anxiety disorder). Furthermore, their findings revealed
inconsistent HPA-Axis functioning within each disorder and even among studies with
similar methodology. They highlight small sample sizes and variations in clinical samples
as potential contributors to these inconsistencies and point to the need for a better
consensus in order to inform future treatment approaches. One possibility for inconsistent
results may be with respect to the time course of cortisol not being adequately studied in
this literature. While many of the above studies have investigated slope differences (e.g.,
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rises and falls) of cortisol over time in anxious individuals (Fiksdal et al., 2019; Michels,
Sioen, Braet, et al., 2013; Murdock et al., 2017; Rotenberg & McGrath, 2016), no study
to our knowledge has investigated incidences of delayed or rapid onset of cortisol after
stress as it relates to anxiety. Although under-studied, trajectory of cortisol may be an
illuminating predictor of anxiety. Another possibility is that there may be other biological
factors related to the HPA-Axis and cortisol that are tied to anxiety and thus driving
discrepant findings.

Heart Rate Variability (HRV) and Anxiety

One such variable is HRV, given that heart rate is a target of cortisol, while HRV
in turn modulates the stress response. As opposed to cortisol, which produces inconsistent
findings, the relationship between HRV and anxiety appears well-established, further
suggesting that HRV may be an important mediating variable for understanding anxietyrelated changes in cortisol. Indeed, many studies demonstrate decreased HRV associated
with anxiety (Chalmers et al., 2014, 2014; Chang et al., 2013; Kemp et al., 2012; Pittig et
al., 2013; Thayer et al., 1996; Watkins et al., 1998) and results of a large meta-analysis,
by Chalmers and colleagues ( 2014), provide further support for reduced resting HRV
among anxious individuals compared to healthy controls. In a review, Friedman (2007)
also found convergent evidence in the literature for a negative association between HRV
and anxiety. In terms of specific evidence, Watkins and colleagues (1998) studied the
relationship between resting baseline HRV and anxiety among healthy adults and found
that, compared to those with low trait anxiety (STAI scores below 31), the high trait
anxiety group (STAI scores above 41) demonstrated significantly decreased vagal control

15
of the heart. Extending this investigation to a clinical group, Klein et al. (1995) compared
individuals with panic disorder (PD) to non-anxious controls and findings suggested that
reduced HRV may be a characteristic of PD. HRV appears to also be a good metric of
anxiety amidst comorbid populations. For example, Chang and colleagues (2013) studied
baseline HRV among anxious individuals with and without comorbid depression
compared to healthy controls and found reduced HRV among the purely anxious group
with an even greater reduction in HRV among the comorbid group. Notably, the authors
excluded patients on antidepressants, as previous studies (Hu et al., 2019; Licht et al.,
2009) suggested antidepressant use may moderate HRV. Similarly, Kemp et al. (2012)
examined resting HRV in an unmedicated sample of adults with comorbid anxiety and
depression, depression alone, and healthy controls. Findings yielded reduced HRV
among the comorbid and purely depressed groups compared to healthy controls, but with
the greatest reduction in the comorbid anxious group.
Expanding on the literature demonstrating reduced HRV at resting baseline,
Friedman and Thayer (1998) found that anxious individuals also presented reduced HRV
compared to healthy controls in response to a laboratory stressor. Likewise, Thayer et al.
(1996) compared autonomic functioning between anxious and non-anxious controls at
resting baseline, relaxation, and worry periods and found lower cardiac vagal control in
the anxious group across all conditions. Furthermore, Pittig et al. (2013) investigated
HRV among a sample of individuals with heterogeneous anxiety disorder diagnoses
compared to healthy controls at baseline and in response to a stressor. Anxious
individuals (regardless of type of formal diagnosis) exhibited significantly lower HRV at
baseline and during the first 30 seconds of the stressor task compared to healthy controls,
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and these effects were independent of gender and age. This suggests that low HRV may
be a unifying feature of trait anxiety.
Notably, the above studies consistently found reduced HRV at resting and in
response to a stressor among individuals with both clinical (e.g., Chalmers et al., 2014;
Klein et al., 1995) and subclinical levels of anxiety (e.g., Watkins et al., 1998) suggesting
that neither the diagnostic status of individuals or state of arousal (relaxed vs. stressed)
changes the pattern of findings (however, see Rajcani et al., 2018) which showed
opposite effects, though in a small sample size [N = 19]).
Concurrent Measures of HRV and Cortisol and Anxiety
As cortisol and HRV are two commonly studied biological underpinnings of trait
anxiety, some researchers have studied these variables together within a single study
design (Michels, Sioen, Braet, et al., 2013; Murdock et al., 2017; Pulopulos et al., 2018).
The impetus for this approach is not only because they are both instrumental in the stress
response, but also because prior literature suggests they may have an influential
relationship on one another (Aimie-Salleh et al., 2019; Rotenberg & McGrath, 2016).
Notably, however, no study investigating the relationship between stress-induced cortisol
and HRV has been done with respect to anxiety, and we report findings below only as
they appear in healthy populations, particularly in adolescents, or in relationship to other
psychological states other than anxiety. First, Pulopulos et al. (2018) explored whether
cortisol response to a laboratory-based stressor was associated with anticipation-induced
or stress task-induced HRV changes among a sample of 171 healthy unmedicated adults.
Salivary samples were taken immediately before introduction to the task, immediately
after the Trier Social Stress Test (TSST), a commonly-employed lab-based social stress
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test, and at 5 points in time in the hour following the TSST to measure cortisol. HRV was
measured continuously from the beginning of the session until 15 minutes following the
TSST. Results revealed that HRV changes during the stress-task were uncorrelated with
cortisol increase or recovery. In contrast, however, a greater decrease in HRV during the
anticipation of stress was correlated with higher stress task-induced cortisol increase, but
not cortisol recovery. These findings indicate that anticipatory HRV, reflective of
individual differences in stress regulation before interaction with a stressor, may be
uniquely important for studying inter-individual differences in cortisol response to stress.
Another study examining the relationship between HRV and cortisol looked at
these variables in relation to hostility in a sample of 213 adults (Murdock et al., 2017).
The researchers investigated if high self-regulatory strength, as reflected by high stressinduced high-frequency HRV (HF-HRV), moderated the effects of hostility on cortisol
secretion. HRV was measured at rest and during the TSST. Saliva samples were collected
immediately before, and six times over a 50 minute time period following, the TSST, to
measure cortisol secretion over time. Results indicated that individuals scoring high on a
self-report measure of hostility were less likely to demonstrate high changes in cortisol
over time when they had high stress-induced HF-HRV. That is, hostility-related changes
in cortisol were moderated by high HRV. These findings suggest that targeting stressinduced HF-HRV may be an appropriate intervention for reducing the impact of hostility
on health outcomes. Notably, Murdock and colleagues (2017) point out that this may, in
part, account for why higher cortisol sensitivity tends to appear more among mood
disordered populations compared to healthy controls (Quax et al., 2013; Young et al.,
2001).
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Finally, in the only study to-date that has investigated the relationship between
cortisol, HRV, and anxiety Michels et al. (2013) found that among children anxiety, peer
problems, anger, and sadness were associated with reduced HRV. Furthermore, they
found that reduced vagal parasympathetic activity was moderately associated with higher
salivary cortisol output and a steeper cortisol diurnal decline. Saliva was collected at
home during two consecutive weekdays at four time points and HRV was measured in a
quiet room for a 10 minute interval and qualified by RMSSD.
In summary, the literature reviewed above indicates that a negative relationship
between HRV and anxiety is well-established, while the relationship between salivary
cortisol and anxiety is less determined. Nevertheless, there is strong evidence to suggest
an interaction between HRV and salivary cortisol. Discrepant findings of cortisol among
anxious individuals suggests that there is a yet-unidentified mechanism influencing the
cortisol stress response in this population. Based on the literature surveyed, we
hypothesize that HRV may be a meaningful moderating variable of the stress response
system in those with high anxiety.
Present Study
While numerous studies have examined salivary cortisol and HRV separately, far
fewer have investigated the relationship between them, and specifically how this
relationship, if present, manifests over time. Importantly, studying these biomarkers
together provides a better depiction of the stress response than either alone (Aimie-Salleh
et al., 2019; Rotenberg & McGrath, 2016), which could hold implications for making
accurate treatment recommendations aimed at improving biological outcomes in clinical
samples. Furthermore, well understood patterns of cortisol and HRV demonstrate that
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these measures fluctuate over time, and in response to stressors, among healthy
populations. Additionally, there is variation in these patterns accounted for by individual
differences. Therefore, the impetus of the present study is to examine the relationship
between cortisol and HRV over time (pre-, during-, post- stress) as well as their
relationship to trait anxiety.
Ultimately, this investigation may lead to a better understanding of these
biological variables, but could yield clinical significance for informing targets of anxiety
intervention. As cortisol is the main output of the stress response it is a logical target of
intervention. However, there are real barriers to using cortisol as an intervention target,
including collecting cortisol for assay or manipulating cortisol in the moment.
Additionally, as outlined above, cortisol follows a delayed response after stress, peaking
typically only 20 minutes later, making it difficult to assess real-time moment-to-moment
changes as they occur in the face of a stressor despite the fact that clinically, targeting
momentary response to stress is a main goal of therapeutic interventions. For these
reasons while readily manipulating cortisol levels may be difficult to achieve, controlling
HRV is more easily accessible and measured in real time. Indeed, prior research has
shown promise for HRV biofeedback as an adjunct treatment modality for reducing stress
among anxious individuals (Henriques et al., 2011; Lehrer & Eddie, 2013). Among those
with major depressive disorder, highly comorbid with anxiety, HRV biofeedback has
demonstrated reduction in depressive symptoms in as little as 4 training sessions and
twice daily 20-minute practice periods at home between sessions (Karavidas et al., 2007).
However, more research is needed to determine whether HRV is related to cortisol in this
population.
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The present study will utilize a large, nationally-representative archival dataset
from the Midlife in the United States Study (MIDUS), which has data on salivary cortisol
and HRV over the course of a psychological and physical stressor. Adults in this dataset
were also characterized on trait anxiety. Thus, this data provides a valuable and relevant
tool for testing of the following aims:
Specific Aims

Aim 1a
Examine variability in the change in salivary cortisol over time (baseline, reactivity to
stressor, recovery). Prior literature demonstrates that individuals differ in their cortisol
response to stressors, at baseline, and recovery; thus, it will be important to understand
differences of this response for respondents in our sample. The intent of this aim is
descriptive in order to quantify change in cortisol over time using pre-established metrics
of response, including an area under the curve with respect to cortisol increase (AUC),
slope to capture the direction of change over time, change in cortisol from baseline to
maximum level after stress, and change in cortisol from maximum level to recovery.
Aim 1b
Re-evaluate change in cortisol over time with a focus on differential trajectories of
cortisol (baseline, reactivity to stressor, recovery). Discrepancies in the literature on
cortisol secretion in anxious populations may, in part, result from lack of a clear
understanding as to how cortisol varies at different points in time. The aforementioned
cortisol metrics in Aim 1a are based on pre-existing traditional methods of analysis and
do not calculate differential timing in rise and decline of cortisol. For example, anxiety
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may not be correlated with magnitude of cortisol rise during stress, but may be related to
an earlier or delayed onset of cortisol rise. Thus, it will also be important to quantify the
trajectory of cortisol over time in this sample.
Aim 1c
Test if trait anxiety is associated with change in cortisol as measured by the above
metrics. We will examine associations between levels of trait anxiety and cortisol
secretion in our sample to better understand if trait levels of anxiety are correlated with
cortisol change as quantified across Aims 1a and 1b.
Aim 2a
To examine variability in the change in HRV over time (baseline, reactivity to stressor,
recovery). Prior literature suggests that high HRV over time and in response to stressors
is an indication of emotion regulation; whereas low HRV signals emotion dysregulation.
Similar to Aim 1a, it will be important to descriptively evaluate how HRV changes over
time in our sample, again using pre-established metrics, including change in HRV from
baseline to stress, and change from stress to recovery.
Aim 2b
Re-evaluate change in HRV over time with a focus on differential trajectories of HRV
(baseline, reactivity to stressor, recovery). Identical to Aim 1b above, we will examine
differential timing in rise and decline of HRV over time through quantification of the
rapid vs. delayed trajectory of HRV over time.
Aim 2c
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Test if trait anxiety is associated with change in HRV as measured by the above metrics.
Again, we will examine associations between levels of trait anxiety and HRV in our
sample to better understand if trait levels of anxiety are correlated with change in HRV as
quantified across Aims 2a and 2b.
Aim 3a
Examine the relationship between change in HRV (baseline, reactivity to stressor,
recovery) and change in cortisol (baseline, reactivity to stressor, recovery). Some prior
findings have shown a relationship between changes in HRV during stress and cortisol
response and/or recovery in healthy samples (Johnsen et al., 2012; Weber et al., 2010).
Other research shows that HRV during the anticipation of stress (but not during stress)
may be associated with cortisol stress response (Pulopulos et al., 2018). Therefore,
studying the relationship between HRV and cortisol in the context of time with regard to
pre-, peri-, and post- stress may be critical to furthering our understanding of these
mechanisms. Furthermore, there is unexplained variance in the cortisol response;
illuminating a possible association between HRV and cortisol that could, in part, help
explain such variance. Thus, we aim to investigate the relationship between HRV and the
cortisol stress response.
Aim 3b
Test the moderating effects of trait anxiety on the relationships between change in HRV
and change in cortisol. This study will ultimately test whether the relationship between
HRV and cortisol is moderated by trait anxiety. Testing this association will help
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illuminate whether HRV as a treatment target for remediation of atypical stress
responding will be relevant for those with high trait anxiety.
Methods

Study Protocol
In 1995, to examine the role of behavioral, psychological, and social factors in
age-related differences in well-being and health, an interdisciplinary team collaborated to
conduct a national survey (N = 3,487) of Midlife Development in the U.S. (MIDUS).
This study was innovative as it allowed researchers to study a large sample of participants
through a wide scientific scope by conducting phone interviews and self-administered
surveys. Based on its success, the National Institute of Aging awarded a grant to the
Institute of Aging at University of Wisconsin-Madison to conduct a follow-up
longitudinal study of the MIDUS respondents, thus leading to the collection of MIDUS 2
data in 2002-2008. The MIDUS 2 study expanded on MIDUS 1 through inclusion of
biological and neurological assessment and therefore MIDUS 2 consisted of five separate
research projects, each collecting different information from sample respondents.
Furthermore, MIDUS 2 added a sample of 600 African Americans from Milwaukee, WI
to improve the focus on health and well-being of African Americans in the U.S..
The study was extended for a third round of funding in 2011-2016 as the Midlife
Development in the U.S. (MIDUS) Refresher study Survey, which recruited a large
sample of midlife adults (N = 3,577) to replenish the original MIDUS 1 baseline cohort.
A second aim was to provide increased sample sizes for testing hypotheses exploring key
variables (e.g., psychological, biological, socioeconomic status) in mid- and later-life
health. Therefore, after completing project 1 respondents were eligible to participate in 4
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additional projects. Data for these projects were obtained during respondents 24 hour stay
at one of 3 Clinical Research Units (CRU), UCLA, Georgetown, and University of
Wisconsin-Madison, and processed at the Columbia University Medical Center in Dr.
Richard Sloan’s laboratory (Appendix A).
Participants
The present study will use data obtained from the publicly available dataset
MIDUS Refresher Biomarker Project, which is one of five projects developed from the
MIDUS Refresher study Survey. From 2012-2016, the MIDUS Refresher Biomarker
study collected data from 863 (n = 746 main sample, n = 117 African Americans from
Milwaukee, WI) of the respondents who had completed the initial MIDUS Refresher
Survey. Respondents’ ages at the time of biomarker data collection ranged from 25 to 78
with females representing 52.1% of the sample and males comprising 47.9% of the
sample.
Procedures
Data for the MIDUS Refresher Biomarker Project were collected after an
overnight stay at CRU. Details on the project’s protocols in full can be found on Midlife
in the United States (MIDUS Refresher): Biomarker Project, 2012-2016 (ICPSR 36901)
website (https://www.icpsr.umich.edu/web/ICPSR/studies/36901). In the morning on the
second day of the CRU stay, data was collected from respondents according to the
Psychophysiology Challenge Protocol, a standard laboratory-based stress reactivity
protocol. Information on respondents’ heart rate, blood pressure (BP), and breathing
while at rest and during challenging tasks was recorded.
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Respondents started seated, at rest, to gather baseline measures over 11 minutes
and then were asked to perform a Stroop color-word matching task or simple arithmetic
task for 6 minutes (counterbalanced), followed by a 6 minute recovery period before
completing the second challenging cognitive task. After completion of the two
challenging tasks and resting recovery periods, respondents were asked to get out of the
chair and stand still for a 6-minute orthostatic stressor. Finally, the respondents returned
to resting in their chair for 30 minutes (Appendix B).
Cortisol
At five predesignated time points during the laboratory-based stress reactivity
protocol, respondents removed a cotton swab from the Salivette ®, put it in their mouth,
rolled it around until saturated, and then placed it back in the tube and replaced the cap
for saliva collection. At the end of each session saliva salivettes were stored in a freezer
at -80 degrees Fahrenheit. At the time of assay cortisol samples were thawed and
centrifuged at 3000 rpm for 5 minutes for cortisol assay (Appendix C). The first salivary
cortisol sample was collected pre-protocol while respondents were standing before
attaching electrocardiogram (ECG) leads and other monitors for cardiovascular
monitoring. Notably, prior literature suggests the importance of a habituation period in
order to avoid elevated cortisol baseline levels (Goodman et al., 2017). Next, a sample
was collected while respondents were seated at baseline, immediately before beginning
the seated baseline physiological recording. The third sample, post-cognitive stress, was
obtained while seated after completion of both cognitive stress tasks and their
corresponding recovery periods. Fourth, a sample was taken standing, directly following
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the orthostatic challenge. Finally, the last sample, recovery, was taken while seated 30
minutes after the orthostatic challenge.
When preparing the saliva samples for assay, the testing lab detected some cases
in which there was insufficient saliva present in the tube to run cortisol assay and these
samples were included in the dataset but flagged. For the purposes of the current study,
participants with insufficient cortisol assays were removed from analyses. Additionally, a
small number of cases were identified during data cleaning for whom the session start
time or the time participant got out of bed that morning was missing or later than
expected due to recording error. Information on wake time was used as a covariate in
analysis given the expected diurnal rise and fall of cortisol based on wake time, but which
is not a focus of this investigation. Missing session start time cases were handled with an
imputed value which was computed using the site-specific mode (50th percentile) of the
lag time in minutes from the session start time to the 1st saliva collection time. Imputed
values for missing wake time cases were computed using the average lag time in minutes
from the blood collection time to the wake time. All cases with imputed values were
flagged and included in the dataset. Of the entire sample (N = 863), data across all 5
cortisol samples were available for N = 757 respondents.
Heart Rate Variability
Throughout the Psychophysiology Challenge Protocol described above,
participants’ cardiovascular reactivity was evaluated by continuous measurement of ECG
and BP was measured at the finger using brachial pressure. The beat-to-beat ECG and BP
waveforms were then analyzed to calculate numerous indices of HRV defined as
variability in the interval between consecutive R waves. While heart rate supplies a

27
measure of the number of heart beats per minute, HRV reflects the variation in time
intervals between consecutive heart beats (Shaffer & Ginsberg, 2017). Data collected
from ECG were analyzed with a specified 300 second epoch duration and
compartmentalized into 7 epochs (Figure 1). Due to the ease of recording short-term
measures of HRV (~5 minutes), this convention appears to be the most widely reported
source of published HRV data (Shaffer & Ginsberg, 2017).
The MIDUS Refresher Biomarker Project collected several measurements of
HRV and the RMSSD was selected for analysis in the present study due to its reliable and
common use in the literature (Hill & Siebenbrock, 2009; Malik et al., 1996). RMSSD
indicates “the beat-to-beat variance in heart rate and is the primary time-domain measure
used to estimate the vagally mediated changes reflected in HRV” (Shaffer & Ginsberg,
2017). Of the entire sample (N = 863), data across all 7 HRV epoch measurements were
available for N = 503 respondents.
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Figure 1. Sequence of 90-minute stress protocol.

Trait Anxiety
Trait anxiety for the present study was measured by participants’ overall scores on
the STAI (Appendix D). The STAI is a self-evaluation questionnaire that consists of 20
items with rankings 1-4 (1= Almost never; 2 = Sometimes; 3 = Often; 4 = Almost
always) and asks respondents to circle the number that “best describes how you generally
feel” (e.g., “I worry too much over something that really doesn’t matter”). Of the entire
sample (N = 863) survey data collection was utilized from project 1, which included a 30minute phone interview followed by two 50-page mailed self-administered
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questionnaires, one of which was the STAI. Scores in the dataset ranged from 20 to 67
(M = 35.16), with higher scores indicating more trait anxiety. The STAI is the goldstandard self-report scale used to measure both trait and state anxiety and is widely used
(Balsamo et al., 2018; Spielberger et al., 1983). Every participant that provided
biomarker data also provided STAI responses (N = 863), therefore, no instances of
missing data for the STAI were identified.
Additional Variables
Based on recommendations in the literature (O’Neal et al., 2016; Silvia et al.,
2014; Sin et al., 2016) the following variables will be used in analyses as covariates in an
effort to increase clarity and understanding of discrepancies in the literature: age, gender,
race, antidepressant use, time of cortisol collection lagged from wake time, and smoking
status.
Age. Age has been identified as a highly important contextual factor in analyzing
variables related to individuals’ stress response. For example, HRV tends to decrease
with age (Umetani et al., 1998). The present study considers participants spanning several
decades (ages 25 to 75), and as such age will be used as a covariate to better understand
variability in the sample across measures.
Gender. Gender may hold important implications for HRV and salivary cortisol
response and therefore will be included for analysis in the present study to better
illuminate and clarify differences. According to previous studies, the upper and lower
limits of HRV appear to be dependent on gender, and gender appears to moderate the rate
at which HRV declines with age (Umetani et al., 1998). Specifically, under age 30
women demonstrated lower HRV compared to men, but these differences diminished
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after age 30 and disappeared by age 50 (Umetani et al., 1998). A meta-analysis conducted
by Zorn and colleagues (2017) also suggests differing cortisol responses to stressors
among men and women.
Antidepressants. Previous studies demonstrate that antidepressants may yield
significant effects on individual’s stress response system (Hu et al., 2019; Kemp et al.,
2012; Licht et al., 2009). As a part of the Refresher Biomarker Project protocol,
comprehensive data about medications participants were taking at time of data collection
were recorded. Participants were directed to bring all their medications, in original
bottles, to their visit to CRU to ensure proper recording of all medication names and
dosages. Current antidepressant use was included as a dichotomous variable (i.e., yes or
no) for each participant in the data set.
Race. Prior literature has suggested race as an important factor in determining
normative and stress response data of HRV. For example, Sin and colleagues (2016)
found higher HRV among African Americans compared to their White counterparts in a
large study. As such, race of participants will be examined in our sample as it relates to
these factors.
Smoking Status. Prior literature has suggested smoking is an important factor in
individual stress response (Adam et al., 2017). As such, smoking status (dichotomous
variable indicating current smoker: yes/no) of participants will be examined in our
sample.
Time of Cortisol Collection. Cortisol follows a known diurnal rhythm, with
levels peaking in the morning, dropping throughout the day, and at its lowest in the
evening (Miller et al., 2007). The cortisol awakening response (CAR), defined by a
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change in cortisol secretion within the first hour of awakening, peaks within about 30-40
minutes of waking and thus is an important factor to consider in salivary cortisol
collection (Steptoe & Serwinski, 2016). Presently, differences in CAR are not the subject
of the present inquiry. As such, only participants who have data available for the duration
between awakening and time of first cortisol collection will be included in the present
study so that lag time between cortisol collection and waking can be controlled for.
Data Analysis
Prior to data analysis, outliers will be reviewed following guidelines from
previous HRV and cortisol research (Pulopulos et al., 2018) and values defined as values
±3 SD will be removed from analysis. If cortisol and HRV measurements are not
approximately normally distributed, we will apply the correct transformation prior to data
analysis. For regression analyses (Aims 3a and 3b), distribution of independent variables
will be assessed for normality and the appropriate transformations will be used to achieve
normal distributions. Results of hierarchical regressions will be evaluated for meeting the
assumptions of the linear model including confirming that errors are independent,
residuals are homoscedastic and normally distributed, and there are no problems with
multicollinearity among predictors.
Owing to a substantial number of proposed tests, we will use a Bonferroni
correction for multiple comparisons for the testing of Aims 1c,2c, 3a, and 3b, our main
study aims examining the relationship between anxiety and cortisol indices (Aim 1c),
anxiety and HRV indices (Aim 2c), HRV and cortisol (Aim 3a), and the moderating role
of anxiety on HRV and cortisol (Aim 3b). Combined, a total of 10 tests will be done, thus
detection of significant effects will be assessed at α = .005 (.05/10 = .005).
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Aim 1a
Examine variability in the change in salivary cortisol over time (baseline, reactivity to
stressor, recovery). Four metrics will be calculated for each participant: (1) an area under
the curve (AUC) based on magnitude response of cortisol across the five timepoints using
the formula from Pruessner et al. (2003), (2) a slope calculated using the collection times
across the five timepoints to capture the direction of change over time, (3) change in
cortisol from baseline to maximum cortisol level using a difference score (maximum –
baseline), referred hereafter as “cortisol reactivity”, and (4) change in cortisol from
maximum to recovery using a difference score (maximum – recovery), referred hereafter
as “cortisol recovery”.
Across the entire sample, means and standard deviations as well as ranges of these
metrics will be calculated and reported for descriptive purposes. Associations with
cortisol metrics and the following variables will also be tested using appropriate
Pearson’s correlations and independent samples t-tests for the identification of relevant
covariates in further analyses: (a) age, (b) gender, (c) race, (d) antidepressant use
(dichotomous variable: 0=no; 1=yes); (e) smoking status (dichotomous variable; 0=no;
1=yes), and (f) lagged time of day first cortisol sample was collected with respect to
waking.
Aim 1a Hypothesis: Given the exploratory and descriptive intent of this aim, we do not
have specific hypotheses with regard to the variability of cortisol metrics in this sample.
Aim 1b
Re-evaluate change in cortisol over time with a focus on differential trajectories of
cortisol (baseline, reactivity to stressor, recovery). To examine if individual trajectories
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of cortisol exist across participants, we will employ latent growth mixture modeling
(LGMM) to study the existence of yet identified differential trajectories of cortisol across
the three time points. LGMM is a data-driven technique to identify interindividual (e.g.,
between-individual) differences in cortisol change based on intraindividual (e.g., withinindividual) change (Ram & Grimm, 2009). LGMM is ideally suited for large samples
sizes (like in the present study) so long as at least three data points for the same measure
can be supplied over time, which we have confirmed for this sample. Sub-groups
identified via LGMM using data-driven methods will be subsequently qualified according
to their cortisol profile (e.g., “blunted early responders” vs. “normal”). To complete
LGMM we will use the R lcmm package; relevant covariates identified in Aim 1 and time
of first cortisol collection will be added and controlled for in the model and BIC will be
used for model selection.
Aim 1b Hypothesis: We anticipate that three sub-groups will emerge: (1) a “normal”
group based on prototypical rise and fall of cortisol over the testing session, (2) a “lateonset”, and (3) an “early-onset” group, with the respective latter groups qualified with
respect to the normal trajectory.
Aim 1c
Test if trait anxiety is associated with change in cortisol as measured by the above
metrics. Continuous STAI scores will be used in Pearson’s correlations to test its
association with cortisol metrics of change identified in Aim 1a. Differences in STAI
scores will be assessed using either independent samples t-tests or ANOVA (depending
on the number of identified sub-groups) for those sub-groups identified via LGMM in
Aim 1b.
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Aim 1c Hypothesis: We hypothesize that trait anxiety will correlate with cortisol metrics
and in accordance with most previous literature, we hypothesize that this relationship will
be negative, such that greater trait anxiety will be related to blunted cortisol responding.
Importantly, we hypothesize that this difference may not present across all metrics, but
rather may be specific to changes in magnitude of response (Aim 1a) or latent trajectory
(Aim 1b).
Aim 2a
To examine variability in the change in HRV over time (baseline, anticipatory, reactivity
to stressor). Three metrics will be calculated for each participant: (1) overall HRV
collapsed across timepoints, (2) change in HRV from baseline to anticipation of the
stressor using a difference score (anticipation – baseline), referred hereafter as “HRV
anticipation”, and (3) change in HRV from anticipation to reactivity to stressor using a
difference score (reactivity – anticipation), referred hereafter as “HRV reactivity”. Across
the entire sample, means and standard deviations as well as ranges of these metrics will
be calculated and reported for descriptive purposes. Associations with HRV metrics and
the following variables will also be done using appropriate Pearson’s correlations and
independent samples t-tests for the identification of possible covariates in further
analyses: (a) age, (b) gender, (c) race, (d) antidepressant use (dichotomous variable: 0 =
no; 1 = yes); and (e) smoking status (dichotomous variable; 0 = no; 1 = yes).
Aim 2a Hypothesis: Given the exploratory and descriptive intent of this aim, we do not
have specific hypotheses with regard to the variability of HRV metrics in this sample.
Aim 2b
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Re-evaluate change in HRV over time with a focus on differential trajectories of HRV
(baseline, reactivity to stressor, recovery). Identical to 1b, we will employ LGMM to
examine sub-groups of individuals based on trajectories of HRV over time. Sub-groups
identified via LGMM will be qualified according to their HRV profile and we will again
complete LGMM using the R lcmm package; relevant covariates identified in Aim 2a will
be added and controlled for in the model and BIC will again be used for model selection.
Aim 2b Hypothesis: We anticipate that three sub-groups will emerge: (1) a “normal”
group based on prototypical rise and fall of HRV over the testing session, (2) a “lateonset”, and (3) an “early-onset” group, with the respective latter groups qualified with
respect to the normal trajectory.
Aim 2c
Test if trait anxiety is associated with change in HRV as measured by the above metrics.
Continuous STAI scores will be used in Pearson’s correlations to test its association with
HRV metrics of change identified in Aim 2a and differences in STAI scores will be
assessed using either independent samples t-tests or ANOVA (depending on the number
of identified sub-groups) for those sub-groups identified via LGMM for HRV trajectories
in Aim 2b.
Aim 2c Hypothesis: We hypothesize that trait anxiety will be negatively correlated with
HRV as measured by the above metrics. That is, we predict that individuals scoring
higher on the trait anxiety will (a) demonstrate lower HRV, (b) less change in HRV over
time, and (c) delayed rise in HRV during stress compared to those scoring low on trait
anxiety.
Aim 3a
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Examine the relationship between change in HRV (baseline, reactivity to stressor,
recovery) and change in cortisol (baseline, reactivity to stressor, recovery). First, we will
calculate the correlation matrix for all cortisol metrics (cortisol AUC, cortisol reactivity,
cortisol recovery, slope, or cortisol trajectory) and HRV metrics (overall HRV, HRV
anticipation, HRV reactivity, HRV trajectory group membership) to determine significant
correlations between HRV and cortisol for use in follow-up hierarchical regression
analyses.
Aim 3a Hypothesis: We hypothesize that, across the sample, greater HRV will
related to less cortisol. Second, we will use a hierarchical regression analysis to test the
relationship between HRV and cortisol controlling for covariates. Step 1 of the model
will include the HRV index correlated with cortisol as identified above as the main
predictor variable; the outcome variable will be one of the pre-identified cortisol indices.
In step 2, we will include covariates of interest as identified in Aims 1a and 2a.
Aim 3b
Test the moderating effects of trait anxiety on the relationships between change in HRV
and change in cortisol. We will repeat the hierarchical linear regression from Aim 3a but
will include STAI continuous scores in Step 2. In the critical step 3, we will create an
interaction term between HRV index and STAI to test its moderating effect on cortisol.
Aim 3b Hypothesis: We hypothesize that the relationship between greater HRV and less
cortisol will be driven by individuals with low trait anxiety and that this relationship will
be comparatively weaker – or absent – in individuals with high trait anxiety.
Results
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Participants
In surveying all aforementioned variables, complete relevant data were available
from N = 480 respondents. In order to test study aims, outliers were reviewed following
guidelines from previous HRV and cortisol research (Pulopulos et al., 2018) and values
±3 SD were removed from analysis. This retained a final sample size of N = 438 for data
analyses.
The sample of N = 438 comprised of 52.7% females (N = 231) and 47.3% males
(N = 207) with an age range of 25 to 75 (M = 48.18, SD = 12.21). Individuals were asked
about their race via the question “What are your main racial origins—that is, what race or
races are your parents, grandparents, and other ancestors”; data regarding racial origins
were available for 376 participants (0.5% Native Hawaiian or Pacific Islander; 1.6%
Native American or Alaska Native Aleutian Islander/Eskimo; 1.8% Asian; 5.9% Other;
5.5% Black and/or African American; 70.5% White). Smoking status (i.e., “do you
currently smoke cigarettes regularly?”) was available for 149 participants in our sample
(Yes, N = 39; No, N = 110). Information about antidepressant use was available for 388
participants (Yes, N = 65; No, N = 323). Based on the availability of all relevant
covariates, a final sample of N = 438 was used for analyses involving cortisol and HRV,
with the exception of LGMM for HRV (N = 388). Regarding the LGMM calculation for
HRV, some covariates were necessary to include in the model (see below); thus,
trimming the sample size to those with available values for covariates (Table 1). To note,
these numbers are higher than the required sample size of N = 114 (estimating α = .05)
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and the sample size of N = 171 (estimating corrected α = .005) identified in our power
analyses to detect medium-sized effects (f2 = .15) with a conserved power of 80%
(completed using G*Power; Faul et al., 2007).

Table 1
Sample demographics.
N = 438
n (%)
231(52.7%)

Gender (female)
Race
Native Hawaiian or Pacific Islander
2(0.5%)
Native American or Alaska Native Aleutian Islander/Eskimo
7(1.6%)
Asian
8(1.8%)
Black and/or African American
24(5.5%)
Other
26(5.9%)
White
309(70.5%)
Smoking status (yes)
39(26.2%)
Antidepressant use (yes)
65(16.8%)
Note. Data on race were available for a total of n = 376 individuals. Smoking status data were
available for n = 149, and antidepressant use data for n = 388.

Testing Aim 1a
Four cortisol metrics were calculated for each participant (N = 438): AUC (M =
4.99, SD = 0.89), slope (M = -0.03, SD = 0.25), cortisol reactivity (M = 0.15, SD =
0.36), and cortisol recovery (M = 0.22, SD = 0.33). With respect to the relationship
between these cortisol metrics and demographics, we found evidence of gender
differences. First, cortisol reactivity was higher in men (M = .21, SD = .37) compared to
women (M = .11, SD = .34), t(436) = -2.95, p = .003). Second, men had greater AUC (M
= 5.15, SD = 0.89) than women (M = 4.85, SD = .87; t(436) = -3.57, p < .001). Finally,
men had a positive slope (M = 0.0002, SD = 0.26) while women had a negative slope (M
= -0.05, SD = 0.23), (t(436) = -2.20, p = .028). In addition, age was significantly
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correlated with AUC (r (436) = .16, p < .001), such that older individuals had greater
AUC.
No significant relationships were detected between any of the cortisol metrics and
smoking status (p > .175), antidepressant use (p > .533), race (p > .144), or wake lag time
(p > .142). Based on the above significant effects, gender and age were included as
covariates in relevant follow-up analyses involving cortisol.
Testing Aim 1b
To examine if individual trajectories of cortisol existed across participants, we
employed LGMM using the R lcmm package; relevant covariates identified in Aim 1 gender and age, and time of first cortisol collection - were added and controlled for in the
model. We compared five models ranging from one to six classes to ensure we selected
the optimal model based on fit. According to standard conventions, model selection was
based on specific selection criteria including the lowest BIC, assuring that greater than
5% of participants were retained in the smallest class subgroup, and theoretical guidance
(Nguena Nguefack et al., 2020). A 3-group solution with the lowest BIC (12515.36)
retained acceptable latent group sizes and also was clinically interpretable, thus this was
selected as the best model fit. The 3-group solution included a “normal” group based on
prototypical rise and fall of cortisol over the testing session (79% of the sample), a
“decline” group that started high and declined throughout the testing session (10% of the
sample), and a “rise” group that started low and increased throughout the testing session
(11% of the sample) as shown in Figure 2.
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In post-hoc analyses, we examined significant differences in the cortisol values
across time within each of the sub-groups. We found that, in the “normal” sub-group,
cortisol was significantly higher at the post-cognitive stressor timepoint with respect to
the baseline (t(343) = 3.27, p = .001), and the 30-minutes post-protocol timepoints (t(343)
= 4.02, p < .001). Additionally, the 30-minutes post-protocol timepoint and baseline did
not differ (t(343) = -1.00, p = .318). In the “decline” sub-group, we found that cortisol
was significantly lower at each subsequent timepoint following arrival (p’s < .010).
Finally, within the “rise” sub-group, we found that cortisol at the post-cognitive stressor
was significantly higher compared to baseline (t(50) = 4.29, p < .001), and significantly
lower compared to the 30-minutes post-protocol timepoint (t(50) = -2.54, p = .014).
Results indicated no significant differences in cortisol between the post-cognitive stressor
and post-physical stressor (t(50) = -1.66, p = .104); further in comparing cortisol 30
minutes post-protocol to that of arrival, individuals remained significantly higher than
arrival (t(50) = 5.83, p < .001). Although the three sub-groups followed significantly
different trajectories throughout the protocol (p’s < .001), results from a one-way
ANOVA revealed that they did not differ significantly from one another at the final
timepoint, 30-minutes post-protocol (F(2, 435) = 1.01, p = .366).
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Figure 2. Cortisol trajectories identified in LGMM analysis.

Testing Aim 1c
Continuous STAI scores were used in Pearson’s correlations to test its association
with cortisol metrics of change identified in Aim 1a. Trait anxiety was negatively
correlated with AUC while controlling for gender and age, although this effect did not
surpass our Bonferroni correction (r(436) = -.10, p = .039). This suggests that greater
anxiety was associated with less cortisol output over the duration of the protocol. STAI
scores were not found to significantly correlate with any other cortisol metrics (p’s >
.197). Differences in STAI scores were assessed using a one-way ANOVA for the three
sub-groups identified via LGMM in Aim 1b. There was not a significant effect of subgroups on STAI scores across the three conditions (F(2, 435) = 0.073, p = .930).
Testing Aim 2a
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Three HRV metrics were calculated for each participant (N = 438) in the sample:
HRV reactivity (M = -0.09, SD = 0.15), HRV anticipation (M = 0.02, SD = 0.07), and
overall HRV (M = 1.25, SD = 0.22). With respect to HRV metrics, we found significant
gender differences on overall HRV (t(436) = 2.63, p = .009), such that women (M = 1.28,
SD = 0.23) had greater HRV than men (M = 1.22, SD = 0.22). Overall HRV also varied
by antidepressant use (t(386) = 2.68, p = .008), such that participants on antidepressants
had lower HRV (M = 1.17, SD = 0.25) compared to participants not on antidepressants
(M = 1.25, SD = 0.21). Age was also significantly correlated with HRV reactivity (r(436)
= .10, p = .038) and overall HRV (r(436) = -.31, p < .001): older individuals had higher
HRV reactivity and lower overall HRV. No significant relationship was detected between
any other HRV metric and smoking status (p > .142), race (p > .113), or wake lag time (p
> .063). Based on the above significant effects, Emp
Testing Aim 2b
Identical to aim 1b, we employed LGMM to examine sub-groups of individuals
based on trajectories of HRV over time. Sub-groups identified via LGMM were qualified
according to their HRV profile and LGMM again was completed using the R lcmm
package; relevant covariates identified in Aim 2a - gender, antidepressant use, and age were added and controlled for in the model and BIC was again used for model selection.
Prior to LGMM analysis, participants with missing data across relevant covariates
were removed from analysis (n = 50 missing antidepressant information) because LGMM
cannot fit individuals with missing data into classes. This left N = 388 for LGMM
analysis, for which five models were tested ranging from one to six classes to again
ensure we selected the optimal model based on fit. According to standard conventions,
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model selection was based on specific selection criteria including the lowest BIC,
assuring that greater than 5% of participants in the smallest class subgroup were retained,
and theoretical guidance (Nguena Nguefack et al., 2020). A 2-group solution with the
lowest BIC (17149.61) retained acceptable latent group sizes and was also clinically
interpretable; thus the 2-group solution was selected to model trajectories of HRV. The 2group solution included a “high and variable” HRV group (58% of the sample), a “low
and variable” HRV group (42% of the sample).
In post-hoc analyses, we examined differences in the HRV values across time
within each of the sub-groups. We found that, in the “high and variable” sub-group, HRV
was significantly lower during the first cognitive stressor in comparison to the second
baseline timepoint (t(218) = -10.64, p < .001) and the first recovery timepoint (t(207) = 7.83, p < .001). Additionally, HRV was significantly lower during the second cognitive
stressor in comparison to the first (t(212) = -7.87, p < .001) and second (t(224) = -10.04,
p < .001) recovery periods. Finally, HRV at the second recovery period was significantly
lower than HRV at the second baseline (t(224) = -3.03, p = .003). This “high and
variable” group did not differ in HRV when comparing cognitive stressor 1 and cognitive
stressor 2 timepoints (t(218) = -0.02, p = .985), meaning that individuals within this
group changed in their HRV between rest and stress timepoints, but maintained the same
HRV values during each stressor. By contrast, the “low and variable” group was also
significantly lower during the first cognitive stressor compared to the second baseline
timepoint (t(156) = -5.38, p < .001) and first recovery period (t(153) = -7.30, p < .001).
Additionally, HRV was significantly lower during the second cognitive stressor in
comparison to the first (t(159) = -3.68, p < .001) and second (t(162) = -6.02, p < .001)
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recovery periods. However, in contrast to the “high and variable” group, the “low and
variable” group demonstrated significantly increased HRV at the second recovery
timepoint in comparison to the second baseline timepoint (t(162) = 3.35, p = .001).
Furthermore, unlike the “high and variable”, the “low and variable” group demonstrated
increased HRV during the second cognitive stressor in comparison to the first cognitive
stressor (t(156) = -2.44, p = .016). Finally, independent samples t-tests revealed that the
two groups differed significantly on measures of HRV reactivity (t(386) = -4.47, p <
.001), and overall HRV (t(386) = 22.16, p < .001) such that the “high and variable” group
exhibited lower HRV reactivity and higher overall HRV than the “low and variable”
group.

Figure 3. HRV trajectories identified in LGMM analysis.

45

Testing Aim 2c
Continuous STAI scores were used in Pearson’s correlations to test its association
with HRV metrics of change identified in Aim 2a, controlling for relevant covariates, and
no significant correlations emerged (p > .402). Likewise, differences in STAI scores were
assessed using independent samples t-tests for the two sub-groups identified via LGMM
for HRV trajectories in Aim 2b, and no significant differences emerged (t(386) = 0.45, p
= .654).
Testing Aim 3a and b
First, we calculated a correlation matrix for all cortisol metrics (cortisol AUC,
cortisol slope, cortisol reactivity, and cortisol recovery) and HRV metrics (overall HRV,
HRV anticipation, and HRV reactivity) (Table 2). Results indicated that HRV reactivity
and cortisol reactivity were significantly correlated (r(436) = .11, p = .024), such that
greater cortisol reactivity was associated with greater HRV reactivity as shown in Figure
4. That is, greater rise in cortisol during the stressors was associated with greater rise in
HRV during the same tasks. No other metrics were significantly correlated (p >.128).
Additionally, chi-square results revealed that the cortisol subgroups and HRV subgroups
identified in trajectory analyses were unrelated to one another (χ2 (2) = .11, p = .945).
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Figure 4. Positive correlation (r = .11) between HRV and cortisol reactivity measures.

Based on the correlation between cortisol reactivity and HRV reactivity, we
carried these two variables forward into a hierarchical regression analysis to test the
relationship between HRV reactivity and cortisol reactivity accounting for covariates. For
all regression analyses, all assumptions of the linear model were met: errors were
independent, residuals were homoscedastic and normally distributed, and there were no
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problems with multicollinearity among predictors. Step 1 of the model that examined
HRV reactivity as a predictor of cortisol reactivity was significant (F(1,436) = 5.10, p =
.024; R2 = .012). A total of 1.2% of the variance in cortisol reactivity was explained by
HRV reactivity.
With the inclusion of covariates of interest (age and gender) in step 2, the model
continued to be significant F(3, 434) = 3.96, p = .004; R2 = .035; R2 change = .023) such
that HRV reactivity continued to be a significant independent predictor of cortisol
reactivity (B = .23, SE = .11, p = .045) (Table 3).
Finally, to test the moderating effects of trait anxiety on the relationships between
change in HRV and change in cortisol we repeated the hierarchical linear regression but
included STAI continuous scores in step 2. Results indicated STAI was not
independently related to cortisol reactivity (B = -.002, SE = .002, p = .232). In step 3, we
created an interaction term, HRV reactivity x STAI, to test its moderating effect on
cortisol. When including this interaction term, the model was not statistically significant
(p = .569). Further, STAI interaction did not moderate the effect of HRV reactivity on
cortisol reactivity (B = .007, SE = .01, p = .569). HRV reactivity also ceased to be an
independent predictor of cortisol reactivity after inclusion of the interaction term (p >
.964) (Table 3).
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Table 3
Hierarchial linear regression testing the moderating effects of trait anxiety on the relationship
between HRV and cortisol reactivity.
Variable
B
SE
β
t
Step 1
Intercept
.18
.02
8.98
HRV reactivity
.25
.11
-.11
-2.26
Step 2
Intercept
.16
.11
1.49
HRV reactivity
.23
.11
-.11
-2.01
Age
.001
.001
.04
.77
Gender
.09
.03
.13
2.62
STAI
-.002
.002
-.06
-1.20
Step 3
Intercept
.13
.12
1.14
HRV reactivity
-.02
.45
.01
.05
Age
.001
.001
.04
.80
Gender
.09
.03
.13
2.61
STAI
-.002
.002
-.04
-.71
Interaction (HRV Reactivity X STAI)
.01
.01
-.11
-.57
Note. Depdendent variable: Cortisol reactivity.

p
<.001
.024
.138
.045
.442
.009
.232
.254
.964
.424
.009
.476
.569

Exploratory Analyses

Restriction to an Anxious Sub-group
The sample reported herein – as a whole – had comparatively low anxiety as
indexed by the STAI using published guidelines suggesting that scores < 38. A score of
38 appears as a reliable cut-off given published evidence that this value is associated with
clinically-detectable anxiety (Kayikcioglu et al., 2017). Thus, we repeated all analyses
above within a sub-sample of individuals with STAI scores > 38. This allowed us to retest the relationship between anxiety, cortisol, and HRV in individuals who may have
clinically-detectable symptoms. Our “highly anxious” sub-sample amounted to N = 152
individuals. To note, this sample is still larger than the N = 114 required (estimating α =
.05) to detect medium-sized effects based on our power analysis.
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In this sample, continuous STAI scores were again used in Pearson’s correlations
to test its association with cortisol metrics of change identified in Aim 1a. Trait anxiety
was negatively correlated with cortisol reactivity while controlling for gender and age
(r(150) = -.17, p = .040). STAI scores were not found to significantly correlate with any
other cortisol metrics (p > .099). Differences in STAI scores were assessed using a oneway ANOVA for the three sub-groups identified via LGMM in Aim 1b and no significant
differences emerged (F(2, 149) = 0.18, p = .837).
Continuous STAI scores were used in Pearson’s correlations to test its association
with HRV metrics of change identified in Aim 2a, controlling for relevant covariates, and
no significant correlations emerged (p > .104). Likewise, differences in STAI scores were
assessed using independent samples t-tests for the two sub-groups identified via LGMM
for HRV trajectories in Aim 2b, and no significant differences emerged (t(137) = 0.69, p
= .491).
Finally, we calculated a correlation matrix for all cortisol metrics (cortisol AUC,
cortisol reactivity, and cortisol recovery) and HRV metrics (overall HRV, HRV
anticipation, and HRV reactivity). None of the metrics were significantly correlated (p >
.120). Additionally, chi-square results revealed that the cortisol subgroups and HRV
subgroups identified in trajectory analyses were unrelated to one another (χ2 (2) = .89, p
= .641).Thus, the hierarchical linear regression testing the association between cortisol
and HRV metrics was not completed in this sub-sample.
Group Differences among LGMM-identified Trajectories
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In addition, as we found no differences in STAI among the LGMM-identified
trajectories, we were interested in other, related, measures that may differ among these
individuals. Namely, we found the differential trajectories interesting and wished to
explore if these individuals differed in other, meaningful ways besides anxiety severity.
Here, our focus was on measures of stress, trauma, depression, and well-being given that
these constructs are highly related to anxiety.
We found that subgroup differences in HRV (p = .387) and cortisol (p = .354) did
not emerge on a measure of trauma, the Childhood Trauma Questionnaire (CTQ) nor did
group differences among HRV (p = .459) or cortisol (p = .900) emerge on a measure of
depression, the Center for Epidemiological Studies Depression (CESD) scale. On a
measure of subjective well-being, the Satisfaction with Life Scale, there were no
differences between HRV groups (p = .906). However, cortisol groups differed on this
measure (F(2, 435) = 3.51, p = .027), such that those in the “decline group” (n = 43) had
significantly higher ratings of subjective well-being (M = 5.22, SD = 1.23) compared to
those in the “normal” (n = 344) group (M = 4.65, SD = 1.35). Those in the “rise” (n = 51)
group (M = 4.73, SD = 1.33) did not significantly differ from either of the other two
groups. Finally, in examining anxious arousal via the Mood and Symptom Questionnaire
(MASQ), we found that differences between the two HRV groups were trending toward
significance (p = .080), such that the “low and variable” group reported greater anxious
arousal compared to the “high and variable” group.
Discussion
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This investigation examined the relationship between cortisol and HRV during
cognitive and physical stress with a particular focus on metrics of change and the
moderating effect of anxiety. Several important results emerged: first, we found that
HRV was a significant predictor of cortisol, such that higher HRV reactivity to cognitive
stress was associated with higher cortisol reactivity to the same stressor. Notably, this
effect persisted after controlling for age and gender differences in HRV and cortisol. We
also found evidence of differential cortisol and HRV trajectories over the course of the
90-minute stress protocol: three sub-groups emerged with respect to their cortisol release
qualified as a “normal” group based on prototypical rise and fall of cortisol over the
testing session, a “decline” group that started high and steadily declined, and a “rise”
group that started low, increased, plateaued, and then continued to rise. By contrast, two
groups emerged with respect to their HRV: a “high and variable” group, and a “low and
variable” group. Despite this and contrary to hypothesis, we did not find support for a
relationship between anxiety and HRV and cortisol metrics in the full sample. Namely,
STAI scores were not related to cortisol or HRV metrics and did not differ among
cortisol and HRV sub-groups identified in the LGMMs. Finally, we found no moderating
effect of trait anxiety on the relationship between changes in HRV and cortisol. In
contrast and in exploratory analyses, we did find that individuals with greater anxiety
exhibited less cortisol reactivity to the cognitive stressor when we restricted our analysis
to a “clinically-detectable” anxious sub-group. Finally, although cortisol sub-groups
identified by the LGMM did not differ in anxiety, we found that individuals in the
“decline” sub-group experienced more subjective well-being in exploratory analyses.
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The lack of an association between cortisol and/or HRV and anxiety was
unexpected. Nonetheless, as we note in the introduction, there are mixed findings
regarding the relationship between cortisol and anxiety, with prior studies finding a
negative relationship (i.e., greater anxiety relates to less cortisol) (de Rooij et al., 2010;
Fiksdal et al., 2019; Jezova et al., 2004), a positive relationship (i.e., greater anxiety
relates to greater cortisol) (Furlan et al., 2001; Yoon & Joormann, 2012), or no
relationship (Henckens et al., 2016; Souza et al., 2015; Young et al., 2004). Thus, our
findings of no relationship between cortisol and anxiety fits with some – but not all – of
this literature. By contrast, there is prior strong evidence for a negative relationship
between resting HRV and trait anxiety, and a negative relationship between HRV during
stress and trait anxiety. Thus, our null effects run counter to this existing framework.
One explanation for a lack of such findings could be that the relationship between
HRV and cortisol with anxiety exists only in individuals high in trait anxiety and is not
detectable at moderate levels. While the STAI ranges from 20-80, the highest score in our
sample was 67, and only 14.4% had scores considered in the highly anxious range (45 or
higher) (Kayikcioglu et al., 2017). Thus, we re-completed all analyses in an exploratory
fashion to test whether these relationships existed in a more anxious “sub-group”
reflecting 34.70% of the full sample. In doing so, we still failed to detect a significant
relationship between HRV and anxiety. To note, sample sizes in both analyses (e.g., full
and reduced samples) were powered to detect moderate effects. However, we did find a
significant relationship between anxiety and cortisol reactivity, such that individuals
higher in trait anxiety exhibited less cortisol reactivity to the cognitive stressor. This
finding aligns with a previous study that also utilized a large sample size (N = 725)
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showing that adults with higher trait anxiety outputted less cortisol in peak response to a
stressor, but that cortisol recovery did not differ in respect to anxiety (de Rooij et al.,
2010). Notably, the previous study demonstrating these results used not only a cognitive
stress task (Stroop), but also a social stress task (a speech test) and calculated peak
cortisol response in the same manner as the present study. Taken together, these findings
suggest that highly anxious individuals, may demonstrate a blunted cortisol response
when confronted with a stressor compared to their low-anxious counterparts.
Our study consistently failed to detect a relationship between HRV and anxiety,
even in our anxious sub-group. One consideration is that much of the previous work has
identified this negative relationship in regards to resting HRV which was not tested
directly in our study. Rather we examined anticipation of HRV as individuals prepared
for a stressor and reactivity to a stressor. Therefore, it could be that the negative
relationship between HRV and anxiety is more robust in resting states outside the
prospect of stress. Indeed, as HRV is expected to decrease in response to stress in healthy
populations, it would need to decrease significantly more to be detected as a difference in
anxious populations. Still, there are some studies that do demonstrate the relationship
during reactivity to stress (Friedman & Thayer, 1998; Pittig et al., 2013; Thayer et al.,
1996). Thus, further investigation of the relationship between HRV and stress reactivity
among anxious adult populations is needed to clarify the nuances of this relationship.
We did find that higher HRV reactivity was associated with higher cortisol
reactivity, and this relationship was not in the expected direction. That is, we found that
individuals with high cortisol reactivity (an increase in cortisol secretion during stress)
have higher HRV reactivity (increased HRV during stress) and conversely, individuals
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with low HRV reactivity scores (decreased HRV during stress) have lower cortisol
reactivity (a decrease in cortisol secretion during stress). This suggests the potential of a
compensatory effect, such that when cortisol is heightened in response to stress, HRV
also increases to promote regulation and a return to homeostasis. To our knowledge only
three other investigations have examined changes over time in cortisol and HRV metrics
in the same study design. One of these studies found that HRV measures during a stresstask were uncorrelated with cortisol; but that lower HRV during anticipation of stress
was correlated with higher stress task-induced cortisol, but not cortisol recovery
(Pulopulos et al., 2018). Another study found that high stress-induced HRV during a
social stress task buffered the moderating effect of hostility on increased cortisol
secretion (Murdock et al., 2017). The third study measured HRV and cortisol at rest from
children at home over two consecutive weekdays and found that lower HRV was
associated with greater cortisol output (Michels, Sioen, Clays, et al., 2013). Two of these
studies examined these variables during a social stress task (Murdock et al., 2017;
Pulopulos et al., 2018), and the third study examined them in children not during a stress
task (Michels, Sioen, Clays, et al., 2013). Therefore, the present study is the first study to
our knowledge that extends the literature to include the examination of this relationship
over time during a cognitive and physical stress task in healthy adults. Notably, the
existence of this relationship suggests HRV as a potential treatment target for improving
effective regulation of stress.
Indeed, HRV can be manipulated in real-time as it can be regulated by breathing
techniques (Henriques et al., 2011). Prior research has already established promise for
HRV biofeedback as an adjunct treatment modality for reducing stress among anxious
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individuals (Lehrer & Eddie, 2013). However, this work points to a need for further
investigations to clarify the mechanisms of change of HRV biofeedback. Our results
suggest one mechanism could be the vagal- HPA axis link in that targeting HRV may
work not only by providing immediate benefit in the moment-to-moment responses, but
also via promoting longer term benefits by altering cortisol over time. While these
biomarkers of stress are typically studied independently, these results suggest merit in
continued research of how they function together. Considering these two biomarkers of
the stress response that are linked with health outcomes, Aimie-Salleh and collegaues
(2019) conducted a study examining HRV and salivary cortisol separately and together.
Results indicated that a fused biomarker (HRV-SCort) representing both the HPA axis
(salivary cortisol) and the ANS (HRV) performed better in discriminating the stress
response than either biomarker on its own. Taken together with the prior literature, results
from this study suggest that while a relationship between vagal activity and the HPA axis
is generally assumed (Thayer & Sternberg, 2006) a closer investigation of the nuances in
this relationship is valuable to informing clinical prognosis and interventions.
In addition to a relationship between HRV and cortisol reactivity in our sample,
we also found evidence of differential trajectories on the five cortisol and seven HRV
measures over time. For cortisol, three groups emerged. Most of the sample (79%)
followed a “normal” trajectory that peaked at timepoint three, post-cognitive stressor, and
then returned to baseline levels by recovery. Notably, cortisol samples collected at
timepoint three occurred approximately 24 minutes after engagement with the first
cognitive stressor. This is aligned with the expected delayed response observed in cortisol
which typically peaks 20 minutes after a stressor. Individuals in the “normal” group then
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returned to baseline levels by cortisol sample five, which occurred 30 minutes after the
physical stressor (a task that required participants to stand still for 6 minutes).
Interestingly, two additional sub-groups emerged that followed opposite patterns (starting
high and dropping versus starting low and rising) throughout the protocol, but ending at
the same levels as the “normal” group 30 minutes post-protocol. A “rise” group (11%)
emerged that started with lower levels of cortisol compared to the other two groups,
which also increased at timepoint three, but then continued to increase until timepoint
five, ending higher than within-group baseline levels. A “decline” group (10%) also
emerged that started higher at baseline compared to the other two groups and declined
throughout the testing protocol, ending at approximately the same levels as the “normal”
group. To note, groups were only differentiated by cortisol before and during the stress
protocol as they exhibited equivalent cortisol values at the end of the protocol.
With respect to the differential trajectories of cortisol release, exploratory
analyses revealed that those in the “decline” group scored higher on subjective ratings of
well-being, compared to those in the “normal” group. This finding is curious given that
these individuals demonstrated higher baseline levels of cortisol, and decreased cortisol
in response to stressors, a pattern that might suggest maladaptive or atypical responding,
but had recovery levels almost identical to those in the “normal” group. One explanation
is that subjective well-being might serve as a stress buffer for individuals with high
baseline cortisol levels. However, more work is needed to explore this possibility.
In regard to HRV, a roughly even split occurred among the sample with over half
following a “high and variable” trajectory and just below half following a “low and
variable” trajectory. The two groups significantly differed on two measures of HRV: the
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"high and variable" group demonstrating higher overall HRV and lower HRV reactivity
(decreased in HRV from baseline to second cognitive stressor – time point five) than the
"low and variable" group. Both sub-groups decreased from baseline to the first cognitive
stressor, increased during the first recovery period, decreased during the second cognitive
stressor, after which they increased during the second recovery period and decreased
again during the physical stressor. However, examination of within-group differences
revealed unique patterns in each group such that the “high and variable” group
demonstrated decreased HRV during the final recovery period in comparison to baseline,
while the “low and variable” group demonstrated increased HRV at the second recovery
timepoint in comparison to baseline. Furthermore, while the “high and variable” group
demonstrated equivalent HRV values during both cognitive stressors, the “low and
variable” group demonstrated increased HRV during the second cognitive stressor in
comparison to the first cognitive stressor.
An advantage of the present study design is that it explores the trajectories over
the course of two recovery periods and two cognitive stressors. It is expected, based on
the literature, that decreases in HRV occur under stress (Endukuru & Tripathi, 2016;
Pulopulos et al., 2018). Therefore, both trajectories exhibiting decreased HRV during the
first cognitive stressor compared to resting or recovery timepoints is aligned with
expected responding. However, it is interesting that the “low and variable” group, but not
the “high and variable” group, demonstrated increased HRV during the second cognitive
stressor compared to the first stressor and exhibited increased HRV during the second
recovery period compared to baseline. One explanation is that an increase in HRV during
stress is a compensatory effect driven by a dysregulated stress response system and that
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while individuals low in overall HRV might respond in the same pattern (decrease HRV)
as individuals with high overall HRV to a single stressor, they might be uniquely
comprised when faced with consecutive stressors. Indeed, when examining anxious
arousal as measured by the MASQ, we found that differences between the two HRV
groups were trending toward significance (p = .080) such that the “low and variable”
group reported greater anxious arousal compared to the “high and variable” group, but
this did not reach significance. Thus, we did not find that anxiety or other exploratory
measures differed between HRV trajectories. Future work is necessary to understand how
HRV trajectories in response to stress differ as a function of physical or mental health
status or other identifiable markers.
Further interrogation of group differences in the trajectories that emerged in the
current study could also help to clarify the positive relationship that was found between
HRV reactivity and cortisol reactivity. The “high and variable” group demonstrated
significantly higher overall HRV, and this group decreased in HRV after the cognitive
stress tasks compared to their HRV levels just prior to the first cognitive stressor. This
could reflect that the higher HRV prior to the tasks served an adaptive function in
preparing the individual to face the stress tasks ahead, and then a decrease in HRV
followed as their sympathetic nervous system activated while engaged in the stressful
tasks. In contrast, the “low and variable” group that demonstrated significantly lower
overall HRV, exhibited an increase in HRV after the cognitive stressors compared to
baseline. Thus, these individuals in preparation for the stressor at baseline were
presumably more dysregulated (lower HRV) but then increased HRV during the stressors
and this remained high at the second recovery period. These trajectories suggest that an
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increase in HRV during stress might serve a compensatory effect, due to a comprised
ability to prepare to face an anticipated stressor. Alternatively, the positive relationship
between HRV reactivity and cognitive reactivity in the full sample indicate that this
compensatory effect could be driven by a comprised ability to respond during stress
(increased cortisol), such that increased cortisol secretion during stress prompts increased
HRV to help regulate. In this case, an increase in HRV and an increase in cortisol during
stress might represent an over-exertion of effort to regulate related to a comprised ability
to respond to stress. However, this could also reflect normal, healthy responding that
when cortisol is low, HRV can adaptively remain low, but that when cortisol is
heightened, an increase in HRV is adaptive. As few studies to date have examined HRV
across repeated cognitive stressors in the same study design future work is needed to
understand what can be expected and considered an adaptive pattern in healthy
populations. The present study offers a starting point of how HRV patterns emerged in
one sample of mid-life adults, but replications are needed to understand if these results
generalize to other populations and to interpret what these patterns signify. Our findings
suggest future work may benefit from examining variability across stress conditions and
resting conditions and considering these in the context of performance metrics on stress
tasks. Additionally, while our reactivity measures captured how individuals changed in
cortisol and HRV in response to stress they do not reflect how much individuals changed.
It is possible that the magnitude of change would provide valuable insight that is left out
of the picture when examining only direction (increase or decrease) of change, and future
studies should examine both.
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A limitation noted in previous work examining HRV and cortisol over time in the
same study design has been that the samples have been either primarily male or female
not allowing for the comparison across genders (Held et al., 2021). A major advantage of
the present study is the large sample size which afforded sufficient variability across
genders, ages, and impact of smoking and antidepressants. Aligned with previous work
(Foley & Kirschbaum, 2010; Zorn et al., 2017) we found evidence for gender differences
in cortisol-mediated response to stress, such that men had greater cortisol reactivity,
AUC, and a positive slope compared to women who had lower cortisol reactivity, less
AUC, and a negative slope. Notably, gender differences to stress have primarily been
explored in response to psychosocial stress, and the present study extends these findings
to cognitive and physical stress. Gender differences also emerged on HRV metrics such
that women had greater overall HRV than men, demonstrating superior ANS regulation.
This finding helps add clarity to the current literature on gender differences in HRV. An
inverse relationship appears at rest (Zachariah & Joseph, 2018) with men demonstrating
higher HRV and while this relationship exists it seems to diminish with age (Umetani et
al., 1998). Notably, the present study utilized RMSSD as a measure of HRV which is a
measure of vagal activity sensitive to short-term changes. Zachariah and Joseph (2018)
also exmained gender differences during a cognitive stress task and found women had
greater HRV than men during the stress task but not at rest, and only on measures of
RMSSD but not on other measures of HRV. Thus, gender differences in HRV may be
context-dependent. More work is needed to explore these differences as HRV is often
utilized as an important biomaker for predicting health outcomes (Zachariah & Joseph,
2018). Additionally, and as expected based on previous findings, age differences emerged

61
such that older individuals had more AUC and lower overall HRV (Umetani et al., 1998),
but also increased HRV reactivity (increase in HRV during stress). Finally, adding
support to results from previous studies we found that participants on antidepressants had
lower overall HRV (Hu et al., 2019; Kemp et al., 2012; Licht et al., 2009). Importantly, in
trajectory analyses we added these covariates, controlling for them in the model; yet,
different trajectories of cortisol and HRV over time were still evident in our sample. This
suggests that there are unaccounted factors other than age, gender, and antidepressant use
that drive individuals into different stress response patterns.
The present study is not without limitations. Of note, although we explored
gender effects in our analyses, we did not include variables related to hormonal changes
associated with menstruation or pregnancy but which are important considerations when
understanding differences in the stress response (Umetani et al., 1998). Furthermore, the
archival data set we used is from 2012-2016 and gender was coded with outdated
methods as a dichotomous variable (female vs. male). Therefore, we were unable to
capture potential gender differences across the full spectrum of gender. Additionally,
while we did not find differences between racial groups, this could be due to the fact that
the sample was lacking in racial diversity (over 70% White). Prior literature has
suggested race as an important factor in determining normative and stress response data
of HRV (Sin et al., 2016). Thus, future work is needed to explore whether racial
differences emerge. Finally, we only examined one measure of anxiety and only two
types of stressors. Thus, the generalizability of our results is limited in that they do not
extend to anxiety disordered populations per se, or to psychosocially stressful situations,

62
which are a major part of daily life that may be particularly relevant for anxious
individuals.
It is well-established that individuals differ in their stress response both via the
HPA-axis (i.e., cortisol) and vagal activity (e.g., HRV) . Further, it is known that these
stress responses change over time and in response to stressors and that this change is
dependent on age, gender, and antidepressant use (Hu et al., 2019; Kemp et al., 2012;
Licht et al., 2009; Umetani et al., 1998; Zachariah & Joseph, 2018). The present study
demonstrated that even after controlling for known variables, different trajectories
emerged for how cortisol and HRV changed over time in response to three different
stressors in a large sample of adults. This indicates that there are indeed unexplained
individual differences over time in cortisol and HRV responses to stressors. Surprisingly,
we found that anxiety levels did not help account for any of these differences.
Interestingly, our results revealed that the only cortisol and HRV measures that tracked
with one another were directions of change on HRV and cortisol reactivity such that a
decrease in HRV during stress (low HRV reactivity) was associated with a decreases in
cortisol during stress (cortisol reactivity). Results from the present study highlight the
importance of the vagal-HPA-axis link as evidenced by an interplay between the changes
in HRV and cortisol stress responding. Results hold clinical relevance in that it may be
possible to promote adaptive long-term responding to stress (desired change in cortisol in
response to stress) via targeting short-term adaptation to stress, HRV, through
biofeedback. However, more research is needed to understand this relationship. Further
examination of these two dynamic biological markers will provide important clarification
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for understanding the human stress response system, and ultimately help to improve
interventions for when this system is disrupted.
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Appendix A
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